T1	intervention 0 52	External beam accelerated partial breast irradiation
T2	control 60 84	whole breast irradiation
T3	eligibility 120 187	women with ductal carcinoma in situ and node-negative breast cancer
T4	location 698 731	Canada, Australia and New Zealand
T5	age 744 761	40 years or older
T6	eligibility 762 859	with ductal carcinoma in situ or node-negative breast cancer treated by breast conserving surgery
T7	outcome-Measure 1212 1255	ipsilateral breast tumour recurrence (IBTR)
T9	total-participants 1699 1703	2135
T10	intervention-participants 1711 1715	1070
T11	control-participants 1759 1763	1065
T12	outcome 2346 2377	8-year cumulative rates of IBTR
T13	iv-bin-percent 2383 2387	3·0%
T14	cv-bin-percent 2427 2431	2·8%
T16	outcome 2556 2580	Acute radiation toxicity
T18	intervention-participants 2700 2704	1070
T20	control-participants 2759 2763	1065
T21	outcome 2785 2808	Late radiation toxicity
T23	intervention-participants 2901 2905	1070
T25	control-participants 2960 2964	1065
T26	outcome 2986 3002	Adverse cosmesis
T27	outcome 3125 3135	at 3 years
T28	outcome 3183 3190	5 years
T29	outcome 3215 3222	7 years
T17	iv-bin-abs 2687 2690	300
T30	iv-bin-percent 2692 2695	28%
T19	cv-bin-abs 2746 2749	484
T31	cv-bin-percent 2751 2754	45%
T22	iv-bin-abs 2888 2891	346
T32	iv-bin-percent 2893 2896	32%
T24	cv-bin-abs 2947 2950	142
T33	cv-bin-percent 2952 2955	13%
T8	outcome 2485 2487	HR
T15	outcome 3341 3355	acute toxicity
